+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition

  • Report

  • 600 Pages
  • April 2023
  • Region: Global
  • Kalorama Information
  • ID: 5315030
Description Jump to:

NOW IN TEN EDITIONS!

While tests run on lab-based analyzers in hospitals and reference labs remain the bedrock of IVD revenues, point of care has always been seen as the growth area.  For as long as the analyst has covered point of care diagnostics, and this now spans 2 decades, point of care tests are the opportunity area.  Point of care as implied in the name is defined as tests that can be meaningful in a provider visit, or in the patient's home.

How can diagnostics promote wellness? How can diagnostics improve patient-provider encounters?  How can tests promote better selection and stewardship of drugs?  How can tests facilitate patient homes or nursing homes of the future? How can diagnostics ensure the next pandemic, if and when it arrives is appropriately handled?  The answers to these questions in many ways rely on the success of point-of-care solutions.

And because of this contribution, Point of Care diagnostics can earn a higher pricing and larger revenue growth than economized lab-based tests.  The tests covered in this report tend to grow at higher rates than the overall IVD market.

Enhanced Segmentation - Many Reports in One

Here are just some of the areas covered in this report

  • Glucose
  • Coagulation
  • CRP
  • Other Cardiac Markers
  • Coagulation
  • Colon Cancer
  • Pregnancy / Fertility
  • Drugs of Abuse
  • hbA1c
  • Cholesterol
  • HIV
  • COVID-19
  • Other Infectious Disease
  • Critical Care Tests

These are detailed with market sizing and forecast in this report.

As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home.

Venue Market Analysis

POC tests are performed in a wide range of geographical locations such as:

  • Hospital departments such as emergency departments, operating rooms, intensive care units, and others
  • Physicians’ offices
  • Hospital clinics
  • Retail clinics
  • Pharmacies
  • Homes - With testing performed by patients, visiting nurses, or other caregivers
  • Nursing homes

POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.

Regional Coverage

POC is an international market and the analyst reflects this with regional coverage.

Analysis is anchored by:

  • Europe
  • Japan
  • United States
  • Rest of World

Other countries and regions discussed in the report include:

  • Australia
  • Canada
  • China
  • France
  • Germany
  • India
  • Italy
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Latin America
  • Middle East

Corporate Profiles

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use.  At the same time, more decentralized test venues invest in non-waived rapid tests and instruments.  POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care.  New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. Rapid tests are beginning to fold into the point of care arena because they allow the physician to treat the patient before they leave the clinic or office.

This report breaks out point of care testing by segment.

Among the top and/or innovative competitors discussed within Corporate Profiles are:

  • 1 Step Detect Associates, Llc
  • Abbott Laboratories
  • Abingdon Health Ltd.
  • Accessbio, Inc.
  • Accubiotech Co, Ltd.
  • Acon Laboratories, Inc
  • Aerscher Diagnostics, Llc
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • Arkray, Inc.
  • Artron Laboratories, Inc
  • Ascensia Diabetes Care Holdings Ag
  • Atlas Link Biotech Co., Ltd
  • Autobio Diagnostics Co., Ltd
  • Beckman Coulter, Inc
  • Becton Dickinson (Bd)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bhat Bio-Tech India Private Ltd. (Bbi)
  • Binx Health
  • Biolytical Laboratories
  • Biomedomics, Inc
  • Biomeme, Inc
  • Biomerica, Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Biosensia Ltd.
  • Biotron Diagnostics, Inc.
  • Boditech Med Inc
  • Boson Biotech Co. Ltd
  • Btnx Inc.
  • Calypte Biomedical Corporation
  • Cepheid, Inc
  • Chembio Diagnostics, Inc.
  • Church & Dwight Co. Inc
  • Clarity Diagnostics, Llc
  • Confirm Biosciences
  • Ctk Biotech, Inc.
  • Cue Health
  • Danaher Corporation
  • Dexcom, Inc
  • Dialab Gmbh
  • Diasys Diagnostic Systems Gmbh
  • Diazyme Laboratories, Inc.
  • Dna Electronics Ltd. (Dnae)
  • Fooke-Achterrath Laboratorien Gmbh
  • Dxgen Corp.
  • Eiken Chemical Co Ltd.
  • Ekf Diagnostics Holdings Plc
  • Elitechgroup S.A.S.
  • Enterix, Inc. (Clinical Genomics)
  • Eurobio Scientific
  • Everlywell
  • Exact Sciences
  • Ey Laboratories
  • First Check Diagnostics Llc
  • Genbio
  • Genedrive Plc
  • Getein Biotech Inc.
  • Glysby Diagnostics
  • Helena Laboratories
  • Hemosure, Inc.
  • Horiba, Ltd.
  • Immune Iq
  • Immunosciences Lab, Inc.
  • Immunostics, Inc
  • Jal Innovation Pte Ltd
  • Jant Pharmacal Corporation
  • Mitra & Co Pvt. Ltd
  • Lamdagen Corporation
  • Lifescan, Inc
  • Lifesign, Llc
  • Lightdeck Diagnostics
  • Lumiradx Uk Limited
  • Macherey-Nagel Gmbh & Co. Kg
  • Medix Biochemica
  • Medmira, Inc
  • Medtronic, Inc.
  • Menarini Diagnostics Srl.
  • Meridian Bioscience, Inc
  • Mico Biomed Usa
  • Nano-Ditech Corporation
  • Ng Biotech
  • Noble Medical, Inc
  • Nova Biomedical Corp.
  • Oasis Diagnostics Corporation
  • Operon S.A.
  • Opko Health, Inc
  • Orasure Technologies, Inc.
  • Polymedco, Inc
  • Polymer Technologies, Inc (Pts Diagnostics)
  • Preventis Gmbh
  • Princeton Biomeditech Corporation
  • Quantumdx Group Limited
  • Quidelortho Corporation
  • Radiometer Medical A/S
  • Randox Laboratories Limited
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Rheonix, Inc
  • Roche Diagnostic Corporation
  • Savyon Diagnostics
  • Sekisui Diagnostics Llc
  • Siemens Healthineers Gmbh
  • Sysmex Corporation
  • Techlab, Inc.
  • Trinity Biotech Plc
  • Trividia Health
  • Tulip Diagnostics Ltd (Tulip Group)
  • Vedalab
  • Veredus Laboratories Pte Ltd
  • Werfen

Scope and Methodology

The geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers.  Additionally, key company profiles are included.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services.  The base year for data was 2022, including updates and reexaminations stemming from the impact of the COVID-19 pandemic. Forecast data is provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for 2022-2026 periods for each segment covered.  Competitive analysis is provided for the year 2022 along with regional breakdowns.  The forecasted market analysis for 2022-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary
  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Table 1-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)
  • Trends Affecting the Market
  • Competitive Outlook
  • Market Conclusions
  • Conclusion One - POC market transformed by technological progress
  • Conclusion Two - POC Molecular Diagnostics continue making inroads
  • Conclusion Three - Prevention and early detection at nexus of POC development
  • Conclusion Four - Wearables continue to influence POC market
  • Conclusion Five - Test cost will continue to be an issue worldwide
  • Conclusion Six - Rising demand will drive POC market in RoW markets
  • Conclusion Seven - New venues - urgent & retail care
  • Conclusion Eight - COVID-19’s positive effect
  • Conclusion Nine - Insurance coverage for OTC COVID-19 testing
  • Conclusion Ten - New Opportunities in POC Infectious Disease Testing
  • Conclusion Eleven - Supply Chain Delays
  • Conclusion Twelve - Multiplex Testing Explodes
  • Conclusion Thirteen - AI Making Inroads into POC
Chapter 2: Introduction and Overview
  • Point-of-Care Diagnostics Testing
  • Industry Regulations
  • Types of CLIA Certificates
  • POC Industry Drivers
  • Patient focused drivers
  • Medical/Healthcare related drivers
  • Technology drivers
  • Economic drivers
  • Other drivers
  • POC Industry Challenges
  • POC Test Types
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath
  • Conditions Evaluated by POC Diagnostic Testing
  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cardiovascular Disease
  • Diabetes
  • Drug Abuse
  • Infectious Disease
  • Herpes
  • HTLV
  • Respiratory Syncytial Virus
  • Hepatitis
  • Lyme Disease
  • Babesiosis
  • Gonorrhea, Syphilis and Chlamydia
  • Trichomonas Vaginalis
  • HIV/AIDS
  • Helicobacter Pylori
  • Influenza
  • Coronavirus
  • Mononucleosis
  • Streptococcus
  • Osteoporosis
  • Pregnancy and Fertility
Chapter 3: POC Blood Glucose Tests
  • Types of Blood Glucose Testing
  • Fasting Blood Sugar (FBS)
  • 2-Hour Postprandial Blood Sugar (PPBS)
  • Random Blood Sugar
  • Glucose Tolerance Test
  • Glucose Urine Test
  • Glycated Hemoglobin (HbA1c)
  • Products
  • Blood Glucose Self-Testing
  • Table 3-1: Selected Glucose Self-Test Meter Innovations
  • Table 3-2: Selected Apps and Glucose Management IT
  • Continuous Self-Testing
  • Glycated Hemoglobin Tests
  • Table 3-3: Selected POC HbA1c Devices
  • Professional
  • Market Size and Growth
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 3-5:  Global POC Diabetes Sales by Test Category, 2022-2027 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
  • Regional Analysis
  • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2022 (%)
  • POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2022-2027 (in millions $ at manufacturer level)
  • POC Continuous Glucose Self-Testing
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2022-2027 (in millions $ at manufacturer level)
  • POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2022-2027 (in millions $ at manufacturer level)
  • POC HbA1c Testing
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2022-2027 (in millions $ at manufacturer level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), 2022 (in millions $)
  • Figure 3-2: Global POC Glucose Test Manufacturers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), by Percent, 2022 (%)
Chapter 4: POC Blood and Electrolytes Testing Market
  • Types of Blood and Electrolytes Tests
  • Hemoglobin/Hematocrit
  • WBC and Other
  • Blood Gases
  • Electrolytes
  • Products
  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2022
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2022
  • Market Size and Growth
  • Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC, Market Analysis), 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 4-4: Global POC Blood & Electrolytes Revenues by Test Category (Blood Gases & Electrolytes, Hematocrit/Hemoglobin, WBC other routines) 2022-2027 ($ millions)
  • Regional Analysis
  • Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis 2022 (%)
  • POC Blood and Electrolyte Self-Testing
  • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • POC Blood and Electrolyte Professional Testing
  • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), 2022 (in millions $)
  • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), by Percent, 2022
Chapter 5: POC Rapid Coagulation
  • Products
  • Table 5-1: Selected POC Coagulation Test Innovations
  • Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations
  • Market Size and Growth
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis 2022 (%)
  • POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Radiometer, Roche Diagnostics, Siemens Healthineers, Werfen, Others), 2022 (in millions$)
  • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers (Abbott, Radiometer, Instrumentation Labs, Roche Diagnostics, Siemens Healthineers, Others), 2022
Chapter 6: POC Rapid Cardiac Markers
  • Products
  • Market Size and Growth
  • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 6-1: POC Rapid Cardiac Markers Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers (Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
  • Figure 6-2: Global POC Cardiac Markers Test Manufacturers (Abbott, QuidelOrtho, Roche, Siemens, Others), by Percent, 2022
Chapter 7: POC Substance Abuse
  • Overview
  • Products
  • Urine
  • Oral
  • Blood
  • Hair
  • Market Size and Growth
  • Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2022-2027 ($ millions at the manufacturer’s level)
  • POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), 2022 (in millions of $)
  • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), by Percent, 2022
Chapter 8: POC Pregnancy and Fertility Testing
  • Products
  • Table 8-1:  Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
  • Market Size and Growth
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers (bioMérieux, Church & Dwight, Meridian, Quidel, SPD, Others), 2022 (in millions $)
  • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers (bioMérieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others), by Percent, 2022
Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing
  • Products
  • Table 9-1: Selected POC Colon Cancer Tests
  • Market Size and Growth
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, Exact Sciences, Others), 2022 (in millions $)
  • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers (Beckman Coulter, Exact Sciences, Others), by Percent, 2022
Chapter 10: POC Infectious Disease Testing
  • Products
  • HIV and Hepatitis
  • Respiratory
  • STD/STI
  • Tropical Diseases
  • Lyme Disease
  • Tuberculosis (TB)
  • Zika
  • Anthrax
  • Other Viruses
  • Hospital Acquired Infections and Sepsis
  • Sepsis
  • C.Diff
  • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
  • COVID-19
  • Antigen
  • Serology
  • Molecular
  • Market Size and Growth
  • Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • POC Infectious Disease Self-Testing
  • Table 10-3: POC Infectious Disease Self-Testing(including COVID-19) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Professional Testing
  • Table 10-4: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Testing by Disease Type
  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type (C. difficile, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza. Malaria, Other Respiratory, STD, Others), 2022 (in millions $)
  • Figure 10-2: Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, E. coli, H. pylori, Home Test/OTC, Others) Percent by Disease Type 2022
  • Figure 10-3: Global Selected POC Infectious Disease (COVID-19, Respiratory, HIV, STD, Hepatitis, C. Diff), Percent by End-user (Hospital including reference labs, physician office labs (POL) and Nursing Homes, pharmacy, home use and others), 2022
  • Competitive Analysis
  • Table 10-6: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
  • Figure 10-4: Global POC Infectious Disease Test Manufacturers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), by Percent, 2022
Chapter 11: POC Lipid Testing
  • Products
  • Market Size and Growth
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • POC Lipid Professional Testing
  • Table 11-3: POC Lipid Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers  2022 (in millions $)
  • Figure 11-2: Global POC Lipid Testing Manufacturers (Abaxis/Zoetis, Abbott, Roche, Others), by Percent, 2022 (%)

Chapter 12: POC Cancer Tumor Marker Testing

  • Products
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
  • Market Size and Growth
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), 2022 (in millions $)
  • Figure 12-2: Global POC Cancer Testing Manufacturers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), by Percent, 2022
Chapter 13: POC Urine Testing
  • Products
  • Market Size and Growth
  • Table 13-1: Global POC Urine Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
  • POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), 2022 (in millions $)
  • Figure 13-2: Global POC Urine Strip Testing Manufacturers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), by Percent, 2022
Chapter 14: Miscellaneous POC Testing
  • Microbiology
  • TSH
  • Allergy
  • Autoimmune
  • Others
  • Market Size and Growth
  • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 14-2:  Global POC Miscellaneous Sales, by Test Category (Microbiology, TSH, Allergy, Autoimmune, Others), 2022-2027 ($ millions)
  • Regional Analysis
  • Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
Chapter 15: Issues and Trends
  • Overview
  • Wearables
  • Table 15-1: Selected Wearable Devices
  • Mobile Healthcare Technologies
  • Telehealth
  • Telehealth eMed to Implement Home Test to Treat Program
  • Patient-centered Healthcare
  • Breath Test Advances
  • Table 15-2: Selected Disease Markers in Exhaled Breath
  • Regulatory Hurdles
  • Reimbursement Challenges
  • PAMA
  • Competition
  • POC and Molecular Diagnostics
  • Table 15-3:  Selected Market Available Molecular POC Diagnostic Platforms
  • POC Biosensors and Microfluidics
  • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2022
  • Table 15-5: Selected Biochip and Biosensor Players, 2022
  • China as a POC Market
  • Emerging POC Technologies
  • POC Connectivity
  • COVID-19 Impact
  • Multiplexed POC Testing
  • Figure 15-1: Multiplexed POC Testing Schematic
  • The Emergence of Non-invasive Technologies
  • Saliva and Swab
  • Optical Techniques
  • Near-infrared Scanning
  • Volatolomics
  • POC and Antibiotic Resistance Concerns
  • Artificial Intelligence in POC
  • POC Future in Infectious Disease Diagnostics
  • Supply Chain Delays
  • Insurance Coverage for OTC Diagnostic Tests
Chapter 16: Total Global POC Testing Market and Competitor Analysis
  • Market Overview
  • Table 16-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)
  • Market Analysis by Product Categories
  • Table 16-2: Global POC Testing Market Analysis by Product Category (Self-Testing, Professional Testing), 2022 (in millions $)
  • Market Analysis by Subcategory
  • POC Self-Testing
  • Table 16-3: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (in millions$)
  • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (%)
  • POC Professional Testing
  • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous), 2022 (in millions$)
  • Figure 16-2: Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose/HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Other), 2022  (by %)
  • POC Testing by End-Use
  • Figure 16-3: POC Testing by End-User (Hospitals and Reference Labs, Nursing Homes/Pharmacies/Home, Physician Office Labs), 2022
  • Market by Device Technology
  • Figure 16-4: Global POC Market by Technology (Analyzers, Biosensor, LFA, Strips), by Sales 2022 by %
  • Market Analysis by Country
  • United States
  • Table 16-5: US POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Europe
  • Table 16-6: Europe POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 16-7: Global POC Testing Market Analysis by European Region, 2022 (in millions $)
  • Germany
  • France
  • UK
  • Switzerland and Sweden
  • Other
  • Figure 16-5: Europe POC Testing Percentage Participation, by Country (France, Germany, Italy, Spain, Switzerland, Sweden, United Kingdom, Others), 2022 (%)
  • Japan
  • Table 16-8: Japan POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Rest of World
  • Latin America
  • China
  • India
  • South Korea
  • Other RoW Countries
  • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America/Middle East/Canada, South Korea/Other Asian Countries, Other), 2022 (in millions $)
  • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America, South Korea, Other), 2022 (%)
  • Table 16-10: Global POC Testing Analysis by Region/Country (Europe, Japan, United States, Rest of World), 2022 (in millions $)
  • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country (Europe, Japan, United States, Rest of World), 2022 (%)
  • COVID-19 Impact
  • Competitive Analysis
  • Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (in millions $)
  • Figure 16-8: Global POC Testing Market Share by Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, bioMérieux, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (%)
Chapter 17: Corporate Profiles
  • Overview
  • 1 Step Detect Associates, LLC
  • Table 17-1: 1-Step Detect Associates Corporate Summary
  • Company Overview
  • Products
  • Abbott Laboratories
  • Table 17-2: Abbott Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-3: Abbott Revenues 2020-2022 (in millions $)
  • Abingdon Health Ltd.
  • Table 17-4: Abingdon Health Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • AccessBio, Inc.
  • Table 17-5: AccessBio Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • AccuBioTech Co, Ltd.
  • Table 17-6: AccuBioTech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • ACON Laboratories, Inc
  • Table 17-7: ACON Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Aerscher Diagnostics, LLC
  • Table 17-8: Aerscher Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Alfa Scientific Designs, Inc
  • Table 17-9: Alfa Scientific Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • American Bio Medica Corporation
  • Table 17-10: American Bio Medica Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • ARKRAY, Inc.
  • Table 17-11: ARKRAY Corporate Summary
  • Company Overview
  • Products
  • Artron Laboratories, Inc
  • Table 17-12: Artron Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Ascensia Diabetes Care Holdings AG
  • Table 17-13: Ascensia Diabetes Care Corporate Summary
  • Company Overview
  • Products
  • Atlas Link Biotech Co., Ltd
  • Table 17-14: Atlas Link Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Autobio Diagnostics Co., Ltd
  • Table 17-15: Autobio Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Beckman Coulter, Inc
  • Table 17-16: Beckman Coulter Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
  • Table 17-17: Beckman Coulter Revenue (2020-2022) ($ millions)
  • Becton Dickinson (BD)
  • Table 17-18: BD Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
  • Table 17-19: BD Corporation Revenue (2020-2022) ($ millions)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Table 17-20:  Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • Table 17-21: Bhat Bio-Tech India Private Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • binx health
  • Table 17-22: binx health Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • bioLytical Laboratories
  • Table 17-23: bioLytical Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • BioMedomics, Inc
  • Table 17-24: BioMedomics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Biomeme, Inc
  • Table 17-25: Biomeme Corporate Summary
  • Company Overview
  • Products
  • Biomerica, Inc.
  • Table 17-26: Biomerica Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
  • Table 17-27: Biomerica Corporation Revenue (2020-2022) ($ millions)
  • bioMérieux SA
  • Table 17-28: bioMerieux SA Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
  • Table 17-29: bioMerieux Revenues (2020-2022) ($ millions)
  • Bio-Rad Laboratories Inc.
  • Table 17-30: Bio-Rad Labs Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-31: Bio-Rad Corporation Revenue (2020-2022) ($ millions)
  • Biosensia Ltd.
  • Table 17-32: Biosensia Corporate Summary
  • Company Overview
  • Products
  • Biotron Diagnostics, Inc.
  • Table 17-33: Biotron Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Boditech Med Inc
  • Table 17-34: Boditech Med Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Boson Biotech Co. Ltd
  • Table 17-35: Boson Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • BTNX Inc.
  • Table 17-36: BTNX Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Calypte Biomedical Corporation
  • Table 17-37: Calypte Biomedical Corporate Summary
  • Company Overview
  • Products
  • Cepheid, Inc
  • Table 17-38: Cephid Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-39: Cepheid Revenues (2020-2022) ($ millions)
  • Chembio Diagnostics, Inc.
  • Table 17-40: Chembio Diagnostic Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-41: Chembio Diagnostics Revenues (2020-2022) ($ millions)
  • Church & Dwight Co. Inc
  • Table 17-42: Church & Dwight Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-43: Church and Dwight Revenues (2020-2022) ($ millions)
  • Clarity Diagnostics, LLC
  • Table 17-44: Clarity Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Confirm Biosciences
  • Table 17-45: Confirm Biosciences Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • CTK Biotech, Inc.
  • Table 17-46: CTK Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Cue Health
  • Table 17-47:  Cue Health Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Danaher Corporation
  • Table 17-48: Danaher Corporation Summary
  • Company Overview
  • Products
  • Dexcom, Inc
  • Table 17-49: Dexcom Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-50:  Dexcom Revenues (2020-2022) ($ millions)
  • DIALAB GmbH
  • Table 17-51: DIALAB Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • DiaSys Diagnostic Systems GmbH
  • Table 17-52: DiaSys Diagnostic Systems Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Diazyme Laboratories, Inc.
  • Table 17-53: Diazyme Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • DNA Electronics Ltd. (DNAe)
  • Table 17-54: DNA Electronics Corporate Summary
  • Company Overview
  • Products
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • Table 17-55:  Dr. Fooke-Achterrath Laboratorien Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • DxGen Corp.
  • Table 17-56:  DxGen Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Eiken Chemical Co Ltd.
  • Table 17-57: Eiken Chemical Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-58:  Eiken Chemical Revenues (2020-2022 ($ millions)
  • EKF Diagnostics Holdings plc
  • Table 17-59: EKF Diagnostics Corporate Summary
  • Company Overview
  • Products
  • ELITechGroup S.A.S.
  • Table 17-60: ELITechGroup Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Enterix, Inc. (Clinical Genomics)
  • Table 17-61: Enterix Corporate Summary
  • Company Overview
  • Products
  • Eurobio Scientific
  • Table 17-62:  Eurobio Scientific Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Everlywell
  • Table 17-63: Everlywell Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Exact Sciences
  • Table 17-64: Exact Sciences Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-65:  Exact Sciences Revenues (2020-2022) ($ millions)
  • EY Laboratories
  • Table 17-66: EY Laboratories Corporate Summary
  • Company Overview
  • Products
  • First Check Diagnostics LLC
  • Table 17-67:  First Check Diagnostics Corporate Summary
  • Company Overview
  • Products
  • GenBio
  • Table 17-68: GenBio Corporate Summary
  • Company Overview
  • Products
  • Genedrive plc
  • Table 17-69: Genedrive Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-70:  Genedrive Revenues (2020-2022) ($ millions)
  • GeTein Biotech Inc.
  • Table 17-71: GeTein Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • GlysBy diagnostics
  • Table 17-72: GlysBy Corporate Summary
  • Company Overview
  • Products
  • Helena Laboratories
  • Table 17-73: Helena Laboratories Corporate Summary
  • Company Overview
  • Products
  • Hemosure, Inc.
  • Table 17-74: Hemosure Corporate Summary
  • Company Overview
  • Products
  • HORIBA, Ltd.
  • Table 17-75: HORIBA Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-76:  HORIBA Revenues (2020-2022) ($ millions)
  • Immune IQ
  • Table 17-77: Immune IQ Corporate Summary
  • Company Overview
  • Products
  • Immunosciences Lab, Inc.
  • Table 17-78: Immunosciences Lab Corporate Summary
  • Company Overview
  • Products
  • Immunostics, Inc
  • Table 17-79: Immunostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • JAL Innovation PTE LTD
  • Table 17-80: JAL Innovation Corporate Summary
  • Company Overview
  • Products
  • Jant Pharmacal Corporation
  • Table 17-81: Jant Pharmacal Corporate Summary
  • Company Overview
  • Products
  • Mitra & Co Pvt. Ltd
  • Table 17-82:  J Mitra Corporate Summary
  • Company Overview
  • Products
  • Covid-19
  • LamdaGen Corporation
  • Table 17-83: LamdaGen Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • LifeScan, Inc
  • Table 17-84: LifeScan Corporate Summary
  • Company Overview
  • Products
  • LifeSign, LLC
  • Table 17-85: LifeSign Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • LightDeck Diagnostics
  • Table 17-86: LightDeck  Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • LumiraDx UK Limited
  • Table 17-87:  LumiraDx Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-88:  LumiraDx (2020-2022) ($ millions)
  • Macherey-Nagel GmbH & Co. KG
  • Table 17-89: Macherey-Nagel Corporate Summary
  • Company Overview
  • Products
  • Medix Biochemica
  • Table 17-90: Medix Biochemica Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • MedMira, Inc
  • Table 17-91: MedMira Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-92:  MedMira Revenues (2020-2022) ($ thousands)
  • Medtronic, Inc.
  • Table 17-93: Medtronic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-94:  Medtronic Revenues (2017-2020) ($ millions)
  • Menarini Diagnostics srl.
  • Table 17-95: Menarini Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Meridian Bioscience, Inc
  • Table 17-96: Meridian Bioscience Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-97:  Meridian Bioscience (2020-2022) ($ millions)
  • MiCo BioMed USA
  • Table 17-98: MiCo BioMed Summary
  • Company Overview
  • Products
  • Nano-Ditech Corporation
  • Table 17-99: Nano-Ditech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • NG Biotech
  • Table 17-100: NG Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Noble Medical, Inc
  • Table 17-101: Noble Medical Corporate Summary
  • Company Overview
  • Products
  • Nova Biomedical Corp.
  • Table 17-102: Nova Biomedical Corporate Summary
  • Company Overview
  • Products
  • Oasis Diagnostics Corporation
  • Table 17-103: Oasis Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Operon S.A.
  • Table 17-104: Operon Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • OPKO Health, Inc
  • Table 17-105: OPKO Health Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-106:  OPKO Health Revenues (2020-2022) ($ millions)
  • OraSure Technologies, Inc.
  • Table 17-107: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-108:  OraSure Revenues (2020-2022) ($ millions)
  • Polymedco, Inc
  • Table 17-109: Polymedco Corporate Summary
  • Company Overview
  • Products
  • Polymer Technologies, Inc (PTS Diagnostics)
  • Table 17-110: Polymer Technologies Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Preventis GmbH
  • Table 17-111: Preventis Corporate Summary
  • Company Overview
  • Products
  • Princeton Biomeditech Corporation
  • Table 17-112: Princeton Biomeditech Corporate Summary
  • Company Overview
  • Products
  • Covid-19
  • QuantuMDx Group Limited
  • Table 17-113: QuantuMDx Group Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • QuidelOrtho Corporation
  • Table 17-114: Quidel Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-115:  QuidelOrtho Revenues (2020-2022) ($ millions)
  • Radiometer Medical A/S
  • Table 17-116: Radiometer Medical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-117:  Radiometer (2020-2022) ($ millions)
  • Randox Laboratories Limited
  • Table 17-118: Randox Labs Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Response Biomedical Corp
  • Table 17-119: Response Biomedical Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Reszon Diagnostics International Sdn. Bhd.
  • Table 17-120: Reszon Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Rheonix, Inc
  • Table 17-121: Rheonix Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Roche Diagnostic Corporation
  • Table 17-122: Roche Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Table 17-123: Roche POC Marketed Products
  • COVID-19
  • Performance Review
  • Table 17-124:  Roche Diagnostics (2020-2022) ($ millions)
  • Savyon Diagnostics
  • Table 17-125: Savyon Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Sekisui Diagnostics LLC
  • Table 17-126: Sekisui Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Siemens Healthineers GmbH
  • Table 17-127: Siemens Healthineers Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-128:  Siemens Healthineers (2020-2022) ($ millions)
  • Sysmex Corporation
  • Table 17-129: Sysmex Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-130: Sysmex (2020-2022) ($ millions)
  • TECHLAB, Inc.
  • Table 17-131: TECHLAB Corporate Summary
  • Company Overview
  • Products
  • Trinity Biotech PLC
  • Table 17-132: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
  • Table 17-133:  Trinity Biotech Revenue (2020-2022) ($ millions)
  • Trividia Health
  • Table 17-134: Trividia Health Corporate Summary
  • Company Overview
  • Products
  • Tulip Diagnostics Ltd (Tulip Group)
  • Table 17-135: Tulip Diagnostics Corporate Summary
  • Company Overview
  • Product
  • COVID-19
  • VedaLab
  • Table 17-136: VedaLab Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Veredus Laboratories PTE Ltd
  • Table 17-137: Veredus Labs Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Werfen
  • Table 17-138:  Werfen Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-139: Werfen (2020-2022) ($ millions)

Companies Mentioned

  • 1 Step Detect Associates, Llc
  • Abbott Laboratories
  • Abingdon Health Ltd.
  • Accessbio, Inc.
  • Accubiotech Co, Ltd.
  • Acon Laboratories, Inc
  • Aerscher Diagnostics, Llc
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • Arkray, Inc.
  • Artron Laboratories, Inc
  • Ascensia Diabetes Care Holdings Ag
  • Atlas Link Biotech Co., Ltd
  • Autobio Diagnostics Co., Ltd
  • Beckman Coulter, Inc
  • Becton Dickinson (Bd)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bhat Bio-Tech India Private Ltd. (Bbi)
  • Binx Health
  • Biolytical Laboratories
  • Biomedomics, Inc
  • Biomeme, Inc
  • Biomerica, Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Biosensia Ltd.
  • Biotron Diagnostics, Inc.
  • Boditech Med Inc
  • Boson Biotech Co. Ltd
  • Btnx Inc.
  • Calypte Biomedical Corporation
  • Cepheid, Inc
  • Chembio Diagnostics, Inc.
  • Church & Dwight Co. Inc
  • Clarity Diagnostics, Llc
  • Confirm Biosciences
  • Ctk Biotech, Inc.
  • Cue Health
  • Danaher Corporation
  • Dexcom, Inc
  • Dialab Gmbh
  • Diasys Diagnostic Systems Gmbh
  • Diazyme Laboratories, Inc.
  • Dna Electronics Ltd. (Dnae)
  • Fooke-Achterrath Laboratorien Gmbh
  • Dxgen Corp.
  • Eiken Chemical Co Ltd.
  • Ekf Diagnostics Holdings Plc
  • Elitechgroup S.A.S.
  • Enterix, Inc. (Clinical Genomics)
  • Eurobio Scientific
  • Everlywell
  • Exact Sciences
  • Ey Laboratories
  • First Check Diagnostics Llc
  • Genbio
  • Genedrive Plc
  • Getein Biotech Inc.
  • Glysby Diagnostics
  • Helena Laboratories
  • Hemosure, Inc.
  • Horiba, Ltd.
  • Immune Iq
  • Immunosciences Lab, Inc.
  • Immunostics, Inc
  • Jal Innovation Pte Ltd
  • Jant Pharmacal Corporation
  • Mitra & Co Pvt. Ltd
  • Lamdagen Corporation
  • Lifescan, Inc
  • Lifesign, Llc
  • Lightdeck Diagnostics
  • Lumiradx Uk Limited
  • Macherey-Nagel Gmbh & Co. Kg
  • Medix Biochemica
  • Medmira, Inc
  • Medtronic, Inc.
  • Menarini Diagnostics Srl.
  • Meridian Bioscience, Inc
  • Mico Biomed Usa
  • Nano-Ditech Corporation
  • Ng Biotech
  • Noble Medical, Inc
  • Nova Biomedical Corp.
  • Oasis Diagnostics Corporation
  • Operon S.A.
  • Opko Health, Inc
  • Orasure Technologies, Inc.
  • Polymedco, Inc
  • Polymer Technologies, Inc (Pts Diagnostics)
  • Preventis Gmbh
  • Princeton Biomeditech Corporation
  • Quantumdx Group Limited
  • Quidelortho Corporation
  • Radiometer Medical A/S
  • Randox Laboratories Limited
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Rheonix, Inc
  • Roche Diagnostic Corporation
  • Savyon Diagnostics
  • Sekisui Diagnostics Llc
  • Siemens Healthineers Gmbh
  • Sysmex Corporation
  • Techlab, Inc.
  • Trinity Biotech Plc
  • Trividia Health
  • Tulip Diagnostics Ltd (Tulip Group)
  • Vedalab
  • Veredus Laboratories Pte Ltd
  • Werfen

Related Topics

Related Reports

Point of Care Diagnostics Global Market Report 2024 - Product Image

Point of Care Diagnostics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
United States Point of Care Diagnostics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Image

United States Point of Care Diagnostics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • 80 Pages
  • United States
From
North America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By Type, By End-use (Clinics, Home Care, Hospitals), By Country, And Segment Forecasts, 2023 - 2030 - Product Image

North America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By Type, By End-use (Clinics, Home Care, Hospitals), By Country, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • North America
From
Point-of-Care Diagnostics: Technologies and Global Markets - Product Image

Point-of-Care Diagnostics: Technologies and Global Markets

  • Report
  • 159 Pages
  • Global
From
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024 - Product Image

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024

  • Report
  • 620 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.